257.77 USD
↗ 0.79 (0.31%)AT CLOSE (11:59 AM EDT)
Johnson & Johnson
JNJNYSE • USD
257.88
↗ 0.11 (0.04%)
POST MARKET (AS OF 07:02 PM EDT)
Post Market
AS OF 07:02 PM EDT
257.88
↗ 0.11 (0.04%)
Market: OPEN
Johnson & Johnson (JNJ) trades at $257.88 per share. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, exceptional Return on Equity (25.9%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, JNJ trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jul 13, 2026.
Open?$257.95
High?$259.53
Low?$256.15
Prev. Close?$256.98
Volume?5.3M
Avg. Volume?8.7M
VWAP?$257.96
Rel. Volume?0.61x
Bid / Ask
Bid?$257.75 × 100
Ask?$258.00 × 200
Spread?$0.25
Midpoint?$257.88
Valuation & Ratios
Market Cap?618.6B
Shares Out?2.4B
Float?2.4B
Float %?100.0%
P/E Ratio?29.40
P/B Ratio?7.62
EPS?$8.74
Dividend?2.02%
Ex-Dividend?N/A
News
Profile
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Themes
Employees
140.8K
Market Cap
618.6B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1944-09-25
Address
ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?98
Momentum?31
Short Sent.?64
Piotroski F-Score?3/9Weak
Altman Z-Score?5.19Safe
Confidence?60%Moderate
Short InterestLow
Short % of Float?1.10%Low
Short Interest?26.6M
Days to Cover?2.5
Free Float2.4B
Avg Daily Volume10.7M
Settlement Date2026-06-30
Financial Health
Current Ratio?1.03Adequate
Quick Ratio?0.77Weak
Cash Ratio?0.38Low
Debt/Equity?0.68Moderate
ValuationFAIRLY VALUEDvs 9 peers + S&P 500
Score56/100
P/E?29.4FAIR▾
Peers63
S&P35
P/B?7.62FAIR▾
Peers38
S&P25
P/S?6.42FAIR▾
Peers50
S&P19
P/FCF?35.5PRICEY▾
Peers43
S&P21
EV/EBITDA?19.5FAIR▾
Peers56
S&P28
EV/Sales?6.77HIGH▾
Peers50
S&P21
Returns & Efficiency
ROE?25.9%STRONG▾
Peers63
S&P75
ROA?10.5%STRONG▾
Peers75
S&P76
Cash Flow & Enterprise
FCF?$17.4B
Enterprise Value?$651.9B
Fundamentals ratios updated end of day